Agf Investments Inc. Moderna, Inc. Transaction History

Agf Investments Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $357,375 - $664,251	-2,826 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$225.82 - $368.51 $301,243 - $491,592	1,334 Added 89.41%	2,826 $718,000
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $965,708 - $2.11 Million	-4,352 Reduced 74.47%	1,492 $574,000
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $36,764 - $66,499	283 Added 5.09%	5,844 $1.37 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $399,380 - $680,314	3,658 Added 192.22%	5,561 $728,000
Q4 2020 Feb 08, 2021	SELL	$65.74 - $169.86 $46.5 Million - $120 Million	-707,444 Reduced 99.73%	1,903 $199,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $11.8 Million - $20.7 Million	217,880 Added 44.33%	709,347 $50.2 Million
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $14.6 Million - $39.3 Million	491,467 New	491,467 $31.6 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.